Narcolepsy Market Size
Market Size in USD Bn
CAGR9.5%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 9.5% |
| Market Concentration | High |
| Major Players | Jazz Pharmaceuticals plc, Takeda Pharmaceutical Company, Teva Pharmaceuticals USA, Inc., Vanda Pharmaceuticals, Kyowa Kirin, Inc. and Among Others |
please let us know !
Narcolepsy Market Analysis
The Narcolepsy Market is estimated to be valued at USD 2.77 Billion in 2025 and is expected to reach USD 5.23 Billion by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032. The increasing prevalence of sleep disorders such as obstructive sleep apnea and increasing awareness about diagnosis and treatment of narcolepsy are contributing to the growth of the market.
The narcolepsy market is expected to witness lucrative growth over the forecast period. Technological advancements in developing novel therapies and drugs as well as growing research activities on identifying the genetic mutations that lead to narcolepsy are anticipated to create new opportunities. Furthermore, increasing healthcare expenditures and improved access to diagnosis and treatment in developing nations will further aid the expansion of the narcolepsy market during the analysis timeframe.